Umami takes the trout out of skincare ingredient
Cell cultivation specialist develops AI model to create key bioactive PDRN
Umami Bioworks, a leading enabler in the development of cell-cultivated fish meat, has created an AI-powered platform for production of an animal-free alternative to a bioactive ingredient made from rainbow trout (Oncorhynchus mykiss) or chum salmon (Oncorhynchus keta) sperm.
Polydeoxyribonucleotide (PDRN) is a fast-growing marine ingredient used in skincare, wound healing, and regenerative medicine.
According to Singapore-based Umami, PDRN production from salmon sperm faces challenges related to supply consistency, ethical concerns, and biosecurity risks. It adds that its proprietary cell biology platform offers a breakthrough alternative: PDRN derived from cultivated marine cell lines under precisely controlled conditions, eliminating the need to transport salmon testicles worldwide and delivering a bioequivalent product.
Optimised yields
“We are rethinking how bioactives like PDRN are made,” said Umami product manager Gayathri Mani. “Our platform provides a scalable, animal-free source of PDRN with optimised yields and the flexibility to meet growing global demand through localised production.”
The global market for PDRN is projected to grow rapidly across skincare and medical applications, fuelled by rising consumer demand for regenerative, anti-ageing, and ethically sourced solutions.
Umami’s ALKEMYST platform is an AI foundation model originally developed to accelerate cell-cultivated seafood production and recently improved to support the broader seafood value chain.
It has now expanded its services further with the launch of the Marine Radiance platform, to produce high-quality, animal-free, and scalable marine bioactives.
